Smoking and cognitive function in Parkinson's disease
- PMID: 17266085
- DOI: 10.1002/mds.21373
Smoking and cognitive function in Parkinson's disease
Abstract
The risk of dementia among Parkinson's disease (PD) patients is greatly elevated compared to controls, yet little is known about determinants of cognitive function among PD patients. We assessed the relation between cigarette smoking prior to disease onset and later cognitive function among PD patients (n = 286) and age- and sex-matched controls (n = 1144) participating in the Nurses' Health Study and Health Professionals Follow-up Study. Both groups completed telephone-administered assessments of cognitive function. We used linear regression to calculate mean differences in cognitive test scores across smoking categories, adjusted for age, education, sex, age at onset of PD, and years since diagnosis. PD patients scored significantly worse on all tests than their matched controls. In analyses only among PD cases, but not among controls, current smokers at PD onset scored worse than never smokers on the Telephone Interview for Cognitive Status (difference = -0.82, 95% CI: -1.33, -0.30, P = 0.002) as well as on a global score combining results of all tests (difference = -0.36, 95% CI: -0.72, 0.01, P = 0.06). This difference was equivalent to the difference in global score observed among controls approximately 10 years apart in age. Analyses of pack-years of smoking prior to disease onset gave similar results. These findings, nested in prospective cohort studies, suggest that cigarette smoking prior to disease onset is associated with worse cognitive function in PD.
Similar articles
-
The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women.Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):41-8. doi: 10.1097/01.wad.0000201850.52707.80. Alzheimer Dis Assoc Disord. 2006. PMID: 16493235
-
Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.J Neurol Sci. 2005 Apr 15;231(1-2):35-9. doi: 10.1016/j.jns.2004.12.003. J Neurol Sci. 2005. PMID: 15792818 Clinical Trial.
-
[Cognition deterioration in Parkinson's disease: associated risk factors].Rev Neurol. 1999 Mar 1-15;28(5):439-43. Rev Neurol. 1999. PMID: 10229953 Spanish.
-
The epidemiology of dementia associated with Parkinson disease.J Neurol Sci. 2010 Feb 15;289(1-2):18-22. doi: 10.1016/j.jns.2009.08.034. Epub 2009 Sep 4. J Neurol Sci. 2010. PMID: 19733364 Review.
-
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.Mov Disord. 2009 Jun 15;24(8):1103-10. doi: 10.1002/mds.22506. Mov Disord. 2009. PMID: 19353727 Review.
Cited by
-
The epidemiology of dementia associated with Parkinson's disease.Brain Pathol. 2010 May;20(3):633-9. doi: 10.1111/j.1750-3639.2009.00369.x. Brain Pathol. 2010. PMID: 20522088 Free PMC article. Review.
-
Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.Eur J Neurol. 2019 Feb;26(2):246-e18. doi: 10.1111/ene.13797. Epub 2018 Oct 28. Eur J Neurol. 2019. PMID: 30169897 Free PMC article.
-
Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives.Int J Mol Sci. 2013 Jul 24;14(8):15286-311. doi: 10.3390/ijms140815286. Int J Mol Sci. 2013. PMID: 23887652 Free PMC article. Review.
-
Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease.J Neurol. 2022 Aug;269(8):4195-4203. doi: 10.1007/s00415-022-11041-x. Epub 2022 Mar 2. J Neurol. 2022. PMID: 35235000 Free PMC article.
-
Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study.Ann Neurol. 2025 Apr;97(4):720-729. doi: 10.1002/ana.27166. Epub 2024 Dec 19. Ann Neurol. 2025. PMID: 39702948
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical